R7BP modulates opiate analgesia and tolerance but not withdrawal

Neuropsychopharmacology

Volumn 37, Issue 4, 2012, Pages 1005-1012

  Terzi, Dimitra ^a   Cao, Yan ^b   Agrimaki, Ioanna ^a   Martemyanov, Kirill A ^b   Zachariou, Venetia ^a  

^a UNIVERSITY OF CRETE   (Greece)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

fentanyl; hot plate; morphine; neuropathic pain; RGS7; RGS9 2

Indexed keywords

BINDING PROTEIN; MORPHINE; R7 FAMILY BINDING PROTEIN; UNCLASSIFIED DRUG;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN; CONTROLLED STUDY; DRUG MECHANISM; DRUG RESPONSE; DRUG TOLERANCE; FEMALE; INFORMATION PROCESSING; KNOCKOUT MOUSE; LOCOMOTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION;

ANALGESICS, OPIOID; ANIMALS; DISEASE MODELS, ANIMAL; DOWN-REGULATION; DRUG TOLERANCE; FEMALE; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MORPHINE DEPENDENCE; RGS PROTEINS; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 84857062419     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2011.284     Document Type: Article

References (36)

1. Anderson GR, Cao Y, Davidson S, Truong HV, Pravetoni M, Thomas MJ et al. (2010). R7BP complexes with RGS9-2 and RGS7 in the striatum differentially control motor learning and locomotor responses to cocaine. Neuropsychopharmacology 35: 1040-1050.
2. Anderson GR, Lujan R, Martemyanov KA (2009). Changes in striatal signaling induce remodeling of RGS complexes containing Gbeta5 and R7BP subunits. Mol Cell Biol 29: 3033-3044.
3. Anderson GR, Lujan R, Semenov A, Pravetoni M, Posokhova EN, Song JH et al. (2007). Expression and localization of RGS9-2/G 5/ R7BP complex in vivo is set by dynamic control of its constitutive degradation by cellular cysteine proteases. J Neurosci 27: 14117-14127. (Pubitemid 351377856)
4. Ballon DR, Flanary PL, Gladue DP, Konopka JB, Dohlman HG, Thorner J (2006). DEP-domain-mediated regulation of GPCR signaling responses. Cell 126: 1079-1093. (Pubitemid 44380291)
5. Berman DM, Gilman AG (1998). Mammalian RGS proteins: Barbarians at the gates. J Biol Chem 273: 1269-1272. (Pubitemid 28133638)
6. Bohn LM, Dykstra LA, Lefkowitz RJ, Caron MG, Barak LS (2004). Relative efficacy is determined by the complements of the G protein-coupled receptor desensitization machinery. Mol Pharmacol 66: 106-112. (Pubitemid 38822092)
7. Bohn LM, Lefkowitz RJ, Gainetdinov RR, Peppel K, Caron MG, Lin FT (1999). Enhanced morphine analgesia in mice lacking b-Arrestin 2. Science 286: 2495-2498.
8. Cabrera-Vera TM, Hernandez S, Earls LR, Medkova M, Sundgren-Andersson AK, Surmeier JD et al. (2004). RGS9-2 modulates D2 dopamine receptor-mediated Ca2+ channel inhibition in rat striatal cholinergic interneurons. Proc Natl Acad Sci 101: 16339-16344. (Pubitemid 39552846)
9. Charlton JJ, Allen BP, Psifogeorgou K, Chakravarty S, Gomes I, Neve RL et al. (2008). Multiple actions of spinophilin modulate mu opioid receptor function. Neuron 58: 238-247. (Pubitemid 351538998)
10. Cheever ML, Snyder JT, Gershnurg S, Siderovski DP, Harden KT, Sondek J (2008). Crystal structure of the multifunctional RGS9-2-Gb5 complex. Nat Strct Mol Biol 15: 155-162. (Pubitemid 351227317)
11. Chen CK, Eversole-Cire P, Zhang H, Mancino V, Chen YJ, He W et al. (2003). Instability of GGL domain containing RGS proteins in mice lacking the G protein beta subunit Gb5. Proc Natl Acad Sci 100: 6604-6609. (Pubitemid 36666628)
12. Chen Y, Geis C, Sommer C (2008). Activation of TRPV1 contributes to morphine tolerance: Involvement of the mitogen-Activated protein kinase signaling pathway. J Neurosci 28: 5836-5845.
13. Dohlman HG, Thorner J (1997). RGS proteins and signaling by heterotrimeric G proteins. J Biol Chem 272: 3871-3874. (Pubitemid 27078439)
14. Drenan RM, Doupnik CA, Boyle MP, Muglia LJ, Huettner JE, Linder ME et al. (2005). Palmitoylation regulates plasma membrane-nuclear shuttling of R7BP, a novel membrane anchor for the RGS7 family. J Cell Biol 169: 623-633. (Pubitemid 41002855)
15. Gold SJ, Hoang CV, Potts BW, Porras G, Pioli E, Kim KW et al. (2007). RGS9-2 negatively modulates L-3,4-dihydroxyphenylalanine-induced dyskinesia in experimental Parkinson's disease. J Neurosci 27: 14338-14348.
16. Gold SJ, Ni YG, Dohlman HG, Nestler EJ (1997). Regulators of Gprotein signaling (RGS) proteins: Region-specific expression of nine subtypes in rat brain. J Neurosci 17: 8024-8037. (Pubitemid 27426238)
17. Han MH, Renthal W, Ring RH, Rahman Z, Psifogeorgou K, Howland D et al. (2010). Brain region specific actions of regulator of G protein signaling 4 oppose morphine reward and dependence but promote analgesia. Biol Psychiatry 67: 761-769.
18. He W, Lu L, Zhang X, El-Hodiri HM, Chen CK, Slep KC et al. (2000). Modules in the photoreceptor RGS9-1.Gbeta 5L GTPaseaccelerating protein complex control effector coupling, GTPase acceleration, protein folding, and stability. J Biol Chem 275: 37093-37100. (Pubitemid 32002127)
19. Hooks SB, Waldo GL, Corbitt ET, Krumins AM, Harden TK (2003). RGS6, RGS7, RGS9 and RGS11 stimulate GTPase activity of Gi family of G proteins with differential selectivity and maximal activity. J Biol Chem 278: 10087-10093. (Pubitemid 36800265)
20. Hu G, Wensel TG (2002). R9AP, a membrane anchor for the photoreceptor GTPase accelerating protein, RGS9-1. Proc Natl Acad Sci 99: 9755-9760. (Pubitemid 34831120)
21. Inturrisi CE (2002). Clinical pharmacology of opioids for pain. Clin J Pain 18(4 Suppl): S3-13.
22. Jayaraman M, Zhou H, Jia L, Cain MD, Blumer KJ (2009). R9AP and R7BP: Traffic cops for the RGS7 family in phototransduction and neuronal GPCR signaling. Trends Pharmacol Sci 30: 17-24.
23. Kovoor A, Seyffarth P, Ebert J, Barghshoon S, Chen CK, Schwarz S et al. (2005). D2 dopamine receptors colocalize regulator of G protein signalling 9-2 via the RGS9 DEP domain, and RGS9 knockout mice develop dyskinesias associated with dopamine pathways. J Neurosci 280: 5133-5136.
24. Kreek MJ (2001). Drug addictions. Molecular and cellular endpoints. Ann NY Acad Sci 937: 27-49. (Pubitemid 32613878)
25. Martemyanov KA, Yoo PJ, Skiba NP, Arshavsky VY (2005). R7BP, a novel neuronal protein interacting with RGS proteins and the R7 subfamily. J Biol Chem 280: 5133-5136. (Pubitemid 40279981)
26. Martemyanov KA, Lishko PV, Calero N, Keresztes G, Solokow M, Strissel KJ et al. (2003). The DEP domain determines subcellular targeting of the GTPase activating protein RGS9 in vivo. J Neurosci 23: 10175-10181. (Pubitemid 37444593)
27. Melief EJ, Miyatake M, Bruchas MR, Chavkin C (2010). Liganddirected c-Jun N-terminal kinase activation disrupts opioid receptor signaling. Proc Natl Acad Sci USA 107: 11608-11613.
28. Moron JA, Zakharova M, Ferrer JE, Merrill GA, Hope B, Lafer EM et al. (2003). Mitogen-Activated protein kinase regulates dopamine transporter surface expression and dopamine transport capacity. J Neurosci 23: 8480-8488. (Pubitemid 37158747)
29. Psifogeorgou K, Papakosta V, Gold SJ, Kardassis D, Zachariou V (2007). RGS9-2 is a negative modulator of mu opioid receptor function. J Neurochem 103: 617-625. (Pubitemid 47498039)
30. Psifogeorgou K, Terzi D, Papachatzaki MM, Varidaki A, Ferguson D, Gold SJ et al. (2011). A unique role of RGS9-2 in the striatum as a positive or negative modulator of opiate actions. J Neurosci 31: 5617-5624.
31. Rahman Z, Schwarz J, Gold SJ, Zachariou V, Wein MN, Choi KH et al. (2003). RGS9 modulates dopamine signaling in the basal ganglia. Neuron 38: 941-952. (Pubitemid 36782384)
32. Sondek J, Siderovski JP (2001). G-g like domains: New frontiers in G protein signalling and b-propeller scaffolding. Biochem Pharmacol 61: 1329-1337.
33. Terzi D, Stergiou E, King SL, Zachariou V (2009). RGS proteins in neuropsychiatric disorders. Progress Mol Biol Trans Sci 86C: 299-333.
34. Traynor JR, Terzi D, Calbarone BJ, Zachariou V (2009). RGS9-2: Probing an intracellular modulator of behaviour as a drug target. Trends Pharmacol Sci 30: 105-111.
35. Xie K, Allen KL, Kourrich S, Colón-Saez J, Thomas MJ, Wickman K et al. (2010). Gbeta5 recruits R7 RGS proteins to GIRK channels to regulate the timing of neuronal inhibitory signaling. Nat Neurosci 13: 661-663.
36. Zachariou V, Georgescu D, Sanchez N, Rahman Z, DiLeone R, Berton O et al. (2003). Essential role for RGS9 in opiate action. Proc Natl Acad Sci 100: 13656-13661. (Pubitemid 37444795)